Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cardiac Safety Profile of First Dose of Fingolimod for Relapsing-Remitting Multiple Sclerosis in Real-World Settings: Data from a German Prospective Multi-Center Observational Study.
Does early (treatment in) BENEFIT lead to late MS benefit?
The Gas6/TAM System and Multiple Sclerosis.
APE1/Ref-1 facilitates recovery of gray and white matter and neurological function after mild stroke injury.
Time- and Region-Specific Season of Birth Effects in Multiple Sclerosis in the United Kingdom.
The quality of cortical network function recovery depends on localization and degree of axonal demyelination.
Screening for SH3TC2 gene mutations in a series of demyelinating recessive Charcot-Marie-Tooth disease (CMT4).
Mutism Caused by Severe Demyelination in a Patient With Marchiafava-Bignami Disease.
Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease.
Poster 373 Paradoxically Increased Rigidity After Intrathecal Baclofen Injection in a Patient with Multiple Sclerosis: A Case Report.
Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome.
Epileptic Phenotype of Two Siblings with Asparagine Synthesis Deficiency Mimics Neonatal Pyridoxine-Dependent Epilepsy.
Management of bladder dysfnction in patients with multiple sclerosis.
Risk of Autoimmunity in EoE and Families: A Population-Based Cohort Study.
The patient's perspective: How to create awareness for improving access to care and treatment of MS patients?
Microglia: Senescence Impairs Clearance of Myelin Debris.
Long-term real life efficacy of onabotulinum toxin A for the treatment of neurogenic detrusor overactivity in a population using intermittent self-catheterization.
Acute Disseminated Encephalomyelitis After Influenza Vaccination: A Case Report.
The Gut Microbiota in Immune-Mediated Inflammatory Diseases.
Reserve-related activities and MRI metrics in multiple sclerosis patients and healthy controls: an observational study.
The association between functional HLA-G 14 bp insertion/deletion and +3142 C>G polymorphisms and susceptibility to multiple sclerosis.
Quality of life in relapsing-remitting multiple sclerosis patients receiving CinnoVex compared with Avonex.
[Anti-NMDA Receptor Antibody-Related Encephalitis].
Interleukin 17 alone is not a discriminant biomarker in early demyelinating spectrum disorders.
Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma.
Pages
« first
‹ previous
…
792
793
794
795
796
797
798
799
800
…
next ›
last »